Science Grants

Following is a selection of grants that have been awarded recently by public and private funding sources. BIOMEDICINE: Six National Cooperative Vaccine Development Groups have been funded by the National Institute of Allergy and Infectious Diseases. Each will be funded for three to five years and will receive approximately $4 million for the first year. The recipient universities and scien- tists are: University of Washington School of Medicine; L. Corey University of Massachusetts Medical

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Following is a selection of grants that have been awarded recently by public and private funding sources.

BIOMEDICINE: Six National Cooperative Vaccine Development Groups have been funded by the National Institute of Allergy and Infectious Diseases. Each will be funded for three to five years and will receive approximately $4 million for the first year. The recipient universities and scien- tists are:

University of Washington School of Medicine; L. Corey

University of Massachusetts Medical Center F.A. Ennis

University of California at Davis School of Medicine; M.B. Gardner

Southwest Foundation for Biomedical Research; R.C. Kennedy

Stanford University School of Medicine; E.S. Mocarski

Whitehead Institute for Biomedical Research; R.A. Young

Research on oncogenes. $631,315 for five years from NIH (under MERIT program to reduce need for renewal applications by outstanding researchers) to Fox Chase Cancer Center, Pa.; M.W. Lieberman

Trauma research center. $3.2 million over five years from NIH to University of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies